Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Moderna (MRNA) Tops Q2 EPS by 32c
August 3, 2023 6:34 AM EDT(Updated - August 3, 2023 7:00 AM EDT)
Moderna (NASDAQ: MRNA) reported Q2 EPS of ($3.62), $0.32 better than the analyst estimate of ($3.94). Revenue for the quarter came in at $344 million versus the consensus estimate of $307.65 million.
Company expecting 2023 COVID-19 vaccine sales of $6 billion to $8... More
Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
August 3, 2023 6:33 AM EDTModerna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
... More